Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections ; volume:19 ; number:1 ; day:19 ; month:6 ; year:2019 ; pages:1-16 ; date:12.2019
BMC health services research ; 19, Heft 1 (19.6.2019), 1-16, 12.2019
- Creator
-
Debaveye, Sam
De Smedt, Delphine
Heirman, Bert
Kavanagh, Shane
Dewulf, Jo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12913-019-4247-2
- URN
-
urn:nbn:de:101:1-2019091114175091715575
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Debaveye, Sam
- De Smedt, Delphine
- Heirman, Bert
- Kavanagh, Shane
- Dewulf, Jo
- SpringerLink (Online service)
Other Objects (12)
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
The cost associated with administering risperidone long-acting injections in the Australian community
Health Status, Disability and Retirement Incentives in Belgium
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
The health-related social costs of alcohol in Belgium
Employment trajectories and mental health-related disability in Belgium
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort study
Variations in Provision of Long-Acting Reversible Contraception Across Veterans Health Administration Facilities
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
The cost associated with administering risperidone long-acting injections in the Australian community
Health Status, Disability and Retirement Incentives in Belgium
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
The health-related social costs of alcohol in Belgium
Employment trajectories and mental health-related disability in Belgium
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort study
Variations in Provision of Long-Acting Reversible Contraception Across Veterans Health Administration Facilities
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
The cost associated with administering risperidone long-acting injections in the Australian community
Health Status, Disability and Retirement Incentives in Belgium
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
The health-related social costs of alcohol in Belgium
Employment trajectories and mental health-related disability in Belgium
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort study